39
Views
10
CrossRef citations to date
0
Altmetric
Review

Hormonal treatment for prostate cancer

&
Pages 493-510 | Published online: 24 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Athanasios G Papatsoris, Danae Liolitsa & Charalambos Deliveliotis. (2007) Manipulation of the nerve growth factor network in prostate cancer. Expert Opinion on Investigational Drugs 16:3, pages 303-309.
Read now

Articles from other publishers (9)

Ivana Z. Kuzminac, Andjelka S. Ćelić, Sofija S. Bekić, Vesna Kojić, Marina P. Savić & Nenad L. Ignjatović. (2022) Hormone receptor binding, selectivity and cytotoxicity of steroid D-homo lactone loaded chitosan nanoparticles for the treatment of breast and prostate cancer cells. Colloids and Surfaces B: Biointerfaces 216, pages 112597.
Crossref
Jin Cao, Sean Hacking, Hector D. Chavarria-Bernal, Tawfiqul A. Bhuiya & Seema Khutti. (2022) Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma. International Journal of Gynecological Pathology 41:1, pages 28-34.
Crossref
Ingvild Løberg Tangen, Therese Bredholt Onyango, Reidun Kopperud, Anna Berg, Mari K. Halle, Anne M. Øyan, Henrica M.J. Werner, Jone Trovik, Karl Henning Kalland, Helga B. Salvesen & Camilla Krakstad. (2016) Androgen receptor as potential therapeutic target in metastatic endometrial cancer. Oncotarget 7:31, pages 49289-49298.
Crossref
Haitao Li, Kenna L. Anderes, Eugenia A. Kraynov, David R. Luthin, Quyen-Quyen Do, Yufeng Hong, Eileen Tompkins, Eric T. Sun, Ranjan Rajapakse, Ved P. Pathak, Lance C. Christie, Haresh Vazir, Rosemary Castillo, Margaret L. Gregory, Mary Castro, Karen Nared-Hood, Genevieve Paderes & Mark B. Anderson. (2006) Discovery of a Novel, Orally Active, Small Molecule Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist. Journal of Medicinal Chemistry 49:11, pages 3362-3367.
Crossref
GERALD ANDRIOLE, DAVID BOSTWICK, FRANCISCO CIVANTOS, JONATHAN EPSTEIN, M. SCOTT LUCIA, JOHN McCONNELL & CLAUS G. ROEHRBORN. (2005) THE EFFECTS OF 5?-REDUCTASE INHIBITORS ON THE NATURAL HISTORY, DETECTION AND GRADING OF PROSTATE CANCER: CURRENT STATE OF KNOWLEDGE. The Journal of Urology 174:6, pages 2098-2104.
Crossref
Nuria Jiménez, Ibane Abasolo, Johan Jongsma, Alfonso Calvo, Mercedes Garayoa, Theodorus H. van der Kwast, Gert J. van Steenbrugge & Luis M. Montuenga. (2003) Androgen‐independent expression of adrenomedullin and peptidylglycine α‐amidating monooxygenase in human prostatic carcinoma. Molecular Carcinogenesis 38:1, pages 14-24.
Crossref
David R. Luthin, Yufeng Hong, Ved P. Pathak, Genevieve Paderes, Karen D. Nared-Hood, Mary A. Castro, Haresh Vazir, Haitao Li, Eileen Tompkins, Lance Christie, John M. May & Mark B. Anderson. (2002) The discovery of novel small molecule non-peptide gonadotropin releasing hormone (GnRH) receptor antagonists. Bioorganic & Medicinal Chemistry Letters 12:23, pages 3467-3470.
Crossref
Piero Periti, Teresita Mazzei & Enrico Mini. (2002) Clinical Pharmacokinetics of Depot Leuprorelin. Clinical Pharmacokinetics 41:7, pages 485-504.
Crossref
V. Albert Cuñat & E. Maestro Castelblanque. (2002) Cáncer de próstata. SEMERGEN - Medicina de Familia 28:6, pages 315-323.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.